Reporting period: 2024-12-31 · Number of holdings: 1
Altitude Crest Partners Inc. disclosed 1 holdings in its latest 13F filing for the period ending 2024-12-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
No holding changes this quarter
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
✓
Ikena Oncology INC
Stock-Other
—
—
—
Portfolio Performance
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 3 months of available history
Based on 38% of reported portfolio value with available pricing
Position changes disclosed by Altitude Crest Partners Inc. for the quarter ending 2024-12-31, including ticker, issuer, weight change, shares change, and action
What is Altitude Crest Partners Inc. and what type of investor is it?
Altitude Crest Partners Inc. is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2024-12-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Altitude Crest Partners Inc.'s largest equity positions?
Based on the latest 13F filing, Altitude Crest Partners Inc.'s top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Altitude Crest Partners Inc. make in its most recent portfolio filing?
No notable portfolio changes were recorded for Altitude Crest Partners Inc. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Altitude Crest Partners Inc. focus on?
Sector breakdown data is not yet available for Altitude Crest Partners Inc.. Check back after the next 13F processing cycle.